LAAE-14, a new in vitro inhibitor of intracellular calcium mobilization, modulates acute and chronic inflammation

Biochemical Pharmacology

Volumn 65, Issue 9, 2003, Pages 1539-1549

  Lucas, Rut ^a   Alves, Mario ^b   Del Olmo, Esther ^b   San Feliciano, Arturo ^b   Payá, Miguel ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Adjuvant arthritis; Human neutrophils; Intracellular calcium; Mouse peritoneal macrophages; Oxidative stress; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; ANTIINFLAMMATORY AGENT; CALCIMYCIN; CALCIUM; CALCIUM IONOPHORE; CYTOCHALASIN B; ETHER DERIVATIVE; IONOMYCIN; LEUKOTRIENE B4; NITRIC OXIDE SYNTHASE; NITRITE; PHENYLALANINE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THAPSIGARGIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEGRANULATION; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; RESPIRATORY BURST; SYNTHESIS;

EID: 0038403695     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00120-5     Document Type: Article

References (44)

1. 2+ influx channels in leukocytes: a therapeutic target? Trends Pharmacol. Sci. 23:2002;63-70.
2. 2+ oscillations. Am. J. Respir. Cell Mol. Biol. 18:1998;32-42.
3. (2+) stores in cell viability and tumor necrosis factor-alpha production of the murine macrophage RAW 264.7 cell line. J. Biomed. Sci. 7:2000;122-127.
4. Hasko G., Szabo C., Nemeth Z.H., Lendvai B., Vizi E.S. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro. Br. J. Pharmacol. 124:1998;1099-1106.
5. 2+ rise and superoxide production. J. Immunol. 165:2000;3992-3998.
6. 2+ mobilization. J. Gastrointest. Surg. 4:2000;150-161.
7. Beutler B.A. The role of tumor necrosis factor in health and disease. J. Rheumatol. 26(suppl 57):1999;16-21.
8. Grabowski P.S., Wright P.K., Van't H., Helfrich M.H., Ohshima H., Ralston S.H. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br. J. Rheumatol. 36:1997;651-655.
9. Nakamura H., Ueki Y., Sakito S., Matsumoto K., Yano M., Miyake S., Tominaga Y., Eguchi K. Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide. Clin. Exp. Rheumatol. 18:2000;445-450.
10. Honda S., Migita K., Hirai Y., Ueki Y., Yamasaki S., Urayama S., Kawabe Y., Fukuda T., Kawakami A., Kamachi M., Kita M., Ida H., Aoyagi T., Eguchi K. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells. Biochem. Biophys. Res. Commun. 268:2000;928-931.
11. 2. Bioorg. Med. Chem. Lett. 10:2000;285-288.
12. Bustos G., Ferrándiz M.L., Sanz M.J., Payá M., Alcaraz M.J. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn Schmiedebergs Arch. Pharmacol. 351:1995;298-304.
13. Gross S.S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:1992;25722-25729.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
15. Betts WH. Detecting oxy radicals by chemiluminescence. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press; 1985. p. 197-201.
16. Thomas P.D., Mao G.D., Rabinovitch A., Poznansky M.J. Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). Biochem. Pharmacol. 45:1993;241-251.
17. 2 with anti-inflammatory activity. J. Pharmacol. Exp. Ther. 282:1997;123-131.
18. Hoult J.R., Moroney M.A., Payá M. Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase. Methods Enzymol. 234:1994;443-454.
19. Tateson J.E., Randall R.W., Reynolds C.H., Jackson W.P., Bhattacherjee P., Salmon J.A., Garland L.G. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br. J. Pharmacol. 94:1988;528-539.
20. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:1993;11-16.
21. Pennanen N., Lapinjoki S., Palander A., Urtti A., Monkkonen J. Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int. J. Immunopharmacol. 17:1995;475-480.
22. Sugishita E., Amagaya S., Ogihara Y. Anti-inflammatory testing methods: comparative evaluation of mice and rats. J. Pharmacobio-Dynam. 4:1981;565-575.
23. Taurog J.D., Argentieri D.C., McReynolds R.A. Adjuvant arthritis. Methods Enzymol. 162:1988;339-355.
24. 2A receptors. Biochem. Pharmacol. 51:1996;957-965.
25. 2+: a critical link in the pathophysiology of sepsis? Proc. Natl. Acad. Sci. U.S.A. 90:1993;3933-3937.
26. Smith J.A. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56:1994;672-686.
27. 2+ influx following receptor activation. Trends Pharmacol. Sci. 12:1991;289-292.
28. Hotchkiss R.S., Bowling W.M., Karl I.E., Osborne D.F., Flye M.W. Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages. Shock. 8:1997;170-178.
29. Jun C.D., Yoon H.J., Park Y.C., Lee S.Y., Kang S.S., Kim H.M., Chung H.T. Synergistic cooperation between thapsigargin and phorbol ester for induction of nitric oxide synthesis in murine peritoneal macrophages. Free Radic. Biol. Med. 20:1996;769-776.
30. Berger F., Borchard U., Hafner D., Weis T. Activation of a potassium outward current by zymosan and opsonized zymosan in mouse peritoneal macrophages. Naunyn Schmiedebergs Arch. Pharmacol. 349:1994;594-601.
31. 2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273:1998;8203-8211.
32. 2 activation. J. Leukoc. Biol. 65:1999;330-336.
33. West M.A., Clair L., Bellingham J. Role of calcium in lipopolysaccharide-stimulated tumor necrosis factor and interleukin-1 signal transduction in naive and endotoxin-tolerant murine macrophages. J. Trauma. 41:1996;647-652.
34. Marriott I., Bost K.L., Mason M.J. Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. J. Cell Physiol. 177:1998;232-240.
35. Ianaro A., O'Donnell C.A., Di Rosa M., Liew F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology. 82:1994;370-375.
36. Sautebin L., Ialenti A., Ianaro A., Di Rosa M. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur. J. Pharmacol. 286:1995;219-222.
37. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7240-7244.
38. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:1995;301-308.
39. Kang R.Y., Freire Moar J., Sigal E., Chu C.Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 35:1996;711-718.
40. Winder C.V., Lembke L.A., Stephens M.D. Comparative bioassay of drugs in adjuvant-induced arthritis in rats: flufenamic acid, mefenamic acid and phenylbutazone. Arthritis Rheum. 12:1969;472-482.
41. van't Hof R.J., Ralston S.H. Nitric oxide and bone. Immunology. 103:2001;255-261.
42. Uesugi M., Yoshida K., Jasin H.E. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J. Immunol. 165:2000;6532-6537.
43. Clancy R.M., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41:1998;1141-1151.
44. 2. Annu. Rev. Pharmacol. Toxicol. 39:1999;175-189.